Correlation Between Coya Therapeutics, and Bioatla
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Bioatla, you can compare the effects of market volatilities on Coya Therapeutics, and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Bioatla.
Diversification Opportunities for Coya Therapeutics, and Bioatla
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Coya and Bioatla is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Bioatla go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Bioatla
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 0.66 times more return on investment than Bioatla. However, Coya Therapeutics, Common is 1.51 times less risky than Bioatla. It trades about -0.19 of its potential returns per unit of risk. Bioatla is currently generating about -0.13 per unit of risk. If you would invest 681.00 in Coya Therapeutics, Common on September 15, 2024 and sell it today you would lose (92.00) from holding Coya Therapeutics, Common or give up 13.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Coya Therapeutics, Common vs. Bioatla
Performance |
| Timeline |
| Coya Therapeutics, Common |
| Bioatla |
Coya Therapeutics, and Bioatla Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coya Therapeutics, and Bioatla
The main advantage of trading using opposite Coya Therapeutics, and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Acumen Pharmaceuticals |
| Bioatla vs. Pmv Pharmaceuticals | Bioatla vs. C4 Therapeutics | Bioatla vs. Nautilus Biotechnology | Bioatla vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |